Citation Impact
Citing Papers
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
2007 Standout
FLT3 inhibitors in acute myeloid leukemia
2018
Cancer treatment and survivorship statistics, 2022
2022 Standout
Sepsis biomarkers: a review
2010 Standout
Doxorubicin-induced cardiomyopathy: From molecular mechanisms to therapeutic strategies
2012 Standout
Persisting low monocyte human leukocyte antigen-DR expression predicts mortality in septic shock
2006
Chronic inflammation in the etiology of disease across the life span
2019 Standout
Intestinal barrier loss as a critical pathogenic link between inflammatory bowel disease and graft-versus-host disease
2015
Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy
2013 Standout
Functions of natural killer cells
2008 Standout
The JAK/STAT signaling pathway: from bench to clinic
2021 Standout
Lymphocyte subset numbers depend on the bacterial origin of sepsis
2003
Targeting the IL-6/JAK/STAT3 signalling axis in cancer
2018 Standout
Extracorporeal photopheresis for bronchiolitis obliterans syndrome after allogeneic stem cell transplant: An emerging therapeutic approach?
2017
Sickle-cell disease
2010 Standout
Endotoxin tolerance: new mechanisms, molecules and clinical significance
2009 Standout
The intestinal epithelial barrier: a therapeutic target?
2016 Standout
Perturbations of both nonregulatory and regulatory FOXP3+ T cells in patients with malignant melanoma
2010 StandoutNobel
Cardioprotective effect of metoprolol and enalapril in doxorubicin‐treated lymphoma patients: A prospective, parallel‐group, randomized, controlled study with 36‐month follow‐up
2010
Cirrhosis-associated immune dysfunction: Distinctive features and clinical relevance
2014 Standout
The anti-inflammatory response dominates after septic shock: association of low monocyte HLA-DR expression and high interleukin-10 concentration
2004
Monitoring Immune Dysfunctions in the Septic Patient: A New Skin for the Old Ceremony
2008
Natural killer cells contribute to the lethality of a murine model of Escherichia coli infection
2002
Defining trained immunity and its role in health and disease
2020 Standout
Pharmacological properties and clinical efficacy of a recently licensed systemic antifungal, caspofungin
2005
Major microbiota dysbiosis in severe obesity: fate after bariatric surgery
2018
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Acute Myeloid Leukemia
2015 Standout
Phenotypic and functional heterogeneity of human NK cells developing after umbilical cord blood transplantation: a role for human cytomegalovirus?
2011
JAK2 inhibitors for myeloproliferative neoplasms: what is next?
2017
Surgical Influence on Th1/Th2 Balance and Monocyte Surface Antigen Expression and Its Relation to Infectious Complications
2003
Myeloproliferative neoplasms: Morphology and clinical practice
2015
Cancer treatment and survivorship statistics, 2016
2016 Standout
Immunosuppression in Patients Who Die of Sepsis and Multiple Organ Failure
2011 Standout
Cancer treatment and survivorship statistics, 2019
2019 Standout
Altered immune function of monocytes in different stages of patients with acute on chronic liver failure
2006
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
2016 Standout
Therapy for myeloproliferative neoplasms: when, which agent, and how?
2014
Works of Markus Ditschkowski being referenced
Early human cytomegalovirus replication after transplantation is associated with a decreased relapse risk: evidence for a putative virus-versus-leukemia effect in acute myeloid leukemia patients
2011
HLA-DR Expression and Soluble HLA-DR Levels in Septic Patients After Trauma
1999
Caspofungin as second-line therapy for fever of unknown origin or invasive fungal infection following allogeneic stem cell transplantation
2005
Bronchiolitis obliterans after allogeneic hematopoietic SCT: further insight—new perspectives?
2013
Outcome of allogeneic stem cell transplantation in patients with myelofibrosis
2004
Endoscopic and Histological Findings Are Predicted by Fecal Calprotectin in Acute Intestinal Graft-Versus-Host-Disease
2016
Toll-like receptor 9, NOD2 and IL23R gene polymorphisms influenced outcome in AML patients transplanted from HLA-identical sibling donors
2010
Long-term survival of sorafenib-treated FLT3-ITD–positive acute myeloid leukaemia patients relapsing after allogeneic stem cell transplantation
2017
Reduced B Cell HLA-DR Expression and Natural Killer Cell Counts in Patients Prone to Sepsis after Injury
1999
Dynamics of bone marrow changes in patients with chronic idiopathic myelofibrosis following allogeneic stem cell transplantation.
2005
Impact of allogeneic stem cell transplantation on survival of patients less than 65 years of age with primary myelofibrosis
2015
Ruxolitinib As Pretreatment Before Allogeneic Stem Cell Transplantation For Myelofibrosis
2013